Petmed Express Inc (PETS) is not a strong buy at this moment for a beginner investor with a long-term horizon. While there are some positive catalysts such as insider buying and a potential short-term upward trend, the company's weak financial performance, bearish technical indicators, and lack of strong trading signals suggest a cautious approach. Holding or waiting for better entry points would be more prudent.
The technical indicators are bearish. The MACD is below zero and negatively contracting, the RSI is neutral at 28.726, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 2.293 and resistance at 2.545.

Insider buying has increased by 174.01% over the last month, indicating confidence from company insiders. Additionally, stocks with similar candlestick patterns show a 100% chance of a 3.14% increase in the next day and a 13.04% increase in the next week.
The company's financial performance is weak, with a significant YoY revenue drop of -21.75% in Q3 2026 and a negative net income of -$10.55M. Gross margin has also declined by -19.33% YoY. No recent news or congress trading data is available to support a positive narrative.
In Q3 2026, revenue dropped by -21.75% YoY to $40.66M, while net income increased to -$10.55M, up 1392.64% YoY. EPS improved to -0.5, up 1566.67% YoY, but gross margin declined to 22.58%, down -19.33% YoY. Overall, the financials indicate a struggling business with some minor improvements in profitability metrics.
No recent analyst rating or price target changes are available for PETS.